Business Context and Reporting Period
Envoy Medical, Inc. (Nasdaq: COCH) filed a Form 8-K on June 19, 2026, reporting corporate governance and executive compensation updates. The company is an emerging growth company incorporated in Delaware, specializing in cochlear implant technology.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation adjustments.
Material Changes
The primary material change reported is the approval by the Compensation Committee of updated compensation terms for Chief Executive Officer Brent Lucas, effective June 19, 2026:
- Base Salary: Increased to $420,000 per year.
- Cash Bonus: Target bonus of $105,000, contingent on strategic performance goals for calendar years 2026 and 2027.
- Stock Options: Grant of 1,000,000 options exercisable at $0.634 per share, vesting over four years.
- Restricted Stock Units (RSUs): Grant of 1,000,000 RSUs with a performance-based vesting condition.
Guidance, Outlook, and Risks
Performance Conditions: The 1,000,000 RSUs granted to the CEO will vest only upon the U.S. Food and Drug Administration (FDA) granting approval (including approval with conditions) for the Company's Acclaim cochlear implant. This approval must be announced between June 19, 2026, and June 18, 2030.
Risks: The vesting of a significant portion of the CEO's equity compensation is contingent on regulatory approval, highlighting the critical importance of the FDA review process for the Acclaim device to the company's executive retention strategy.
Investor Verification Checklist
- Verify the current status of the FDA review for the Acclaim cochlear implant.
- Confirm the specific strategic performance goals tied to the $105,000 cash bonus.
- Review the full text of the RSU Award Grant Notice (Exhibit 10.1) for additional vesting terms or forfeiture conditions.
- Assess the impact of the $0.634 exercise price on potential dilution if the stock price appreciates significantly.